Journal of Virology · 2019 · 50 citations · 54 references
Life SciencesImmunologyInfectious DiseasesAntibody EngineeringMolecular VirologyVaccinologyAntigen DesignAntiviral ImmunityVaccinationVaccine Antigen DesignVaccine Antigen DiscoveryViral VaccinesAnimal Challenge ModelsPassive Antibody ProtectionPreventive Subunit VaccinesProtective Antibody TitersSubunit Vaccine ImmunogenicityTherapeutic Subunit VaccinesVaccine Candidate AntigensZika Virus Vaccines
Viral subunit vaccines generally show low efficacy. In this study, we revealed an intrinsic limitation of subunit vaccine designs: artificially exposed surfaces of subunit vaccines contain epitopes unfavorable for vaccine efficacy. More specifically, we identified an epitope on Zika virus (ZIKV) envelope protein domain III (EDIII) that is buried in the full-length envelope protein but becomes exposed in recombinant EDIII. We further shielded this epitope with a glycan, and the resulting mutant EDIII vaccine demonstrated significantly enhanced efficacy over the wild-type EDIII vaccine in protecting animal models from ZIKV infections. Therefore, the intrinsic limitation of subunit vaccines can be overcome through shielding these artificially exposed unfavorable epitopes. The engineered EDIII vaccine generated in this study is a promising vaccine candidate that can be further developed to battle ZIKV infections.
54
Guide for the Care and Use of Laboratory Animals (8th edn)
Udo Albus · Laboratory Animals · 2012 · 1.7K citations · Full text
Modified mRNA Vaccines Protect against Zika Virus Infection
Justin M. Richner, Sunny Himansu, Kimberly A. Dowd et al. · Cell · 2017 · 898 citations · Full text
The 3.8 Å resolution cryo-EM structure of Zika virus
Devika Sirohi, Zhenguo Chen, Lei Sun et al. · Science · 2016 · 747 citations